Vaccine News and Research

Latest Vaccine News and Research

Dual therapeutic potential of zapnometinib against COVID-19

Researchers assessed the impact of the drug zapnometinib on human immune response against coronavirus disease 2019.

2 Mar 2022

Durability of immunity to SARS-CoV-2 reinfection among initially unvaccinated individuals with previous SARS-CoV-2 infection

An new study published presents evidence that a prior history of infection with SARS-CoV-2 provides immunity that prevents reinfection for at least a year.

2 Mar 2022

Antigenic differences between Omicron BA.1 and BA.2 SARS-CoV-2 variants

A new study identifies the antigenic differences that exist between the Omicron BA.2 and BA.1 variants.

2 Mar 2022

Short-term change of depressive and anxiety symptoms in relation to COVID-19 vaccination

Researchers assess the short-term impacts of vaccination on the mental health of Swedish adults, with a primary focus on depression and anxiety.

2 Mar 2022

UK's bilateral donation of 1 million vaccine doses will reinforce Bangladesh’s fight against COVID-19

The UK bilaterally donated 1 million doses of the Oxford-AstraZeneca vaccine to Bangladesh. The vaccine consignment arrived in Bangladesh on 23 February 2022.

2 Mar 2022

Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis

The current study discusses a reliable ELISA that can detect three isotypes of antibody against three SARS-CoV-2 antigens.

2 Mar 2022

Government invests £260 million to support health research and life sciences manufacturing

Patients across the country are set to benefit from cutting-edge medical advances and treatments as the government invests £260 million today (Wednesday 2 March) to support research and development, as well as the manufacturing of new drugs, devices and diagnostics.

2 Mar 2022

Study reports substantial loss of protection one month after complete SARS-CoV-2 BNT162b2 immunization in children

A new study evaluated the efficacy of Pfizer’s BNT162b2 vaccine in children aged 17 years or younger after the emergence of the SARS-CoV-2 Omicron variant.

2 Mar 2022

Population-level health and economic impact of the Pfizer-BioNTech COVID-19 vaccine in first year of rollout in the US

A new study shows the impact of the vaccine program on the state of public health in the USA.

2 Mar 2022

Study finds booster shot did produce effective levels of neutralizing antibodies against omicron

A new study using serum from human blood samples suggests neutralizing antibody levels produced by two-dose mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer essentially no protection against the omicron variant.

2 Mar 2022

Researchers launch a multi-center trial to investigate new treatment for pediatric type 1 diabetes

Researchers at Massachusetts General Hospital, in partnership with NYU Langone Health, have launched a multi-center clinical trial to investigate a new treatment for pediatric type 1 diabetes even in subjects with established disease.

1 Mar 2022

mRNA vaccines found to generate neutralizing antibodies against SARS-CoV-2 Omicron variant

A new study assessed the immunogenicity of messenger-ribonucleic acid vaccines to generate cross-reactive neutralizing antibodies against the SARS-CoV-2 Omicron variant in convalescent COVID-19 patients.

1 Mar 2022

Risk of death involving COVID-19 following infection from Omicron relative to Delta

Researchers conducted a retrospective study on a cohort of patients in England with SARS-CoV-2 positive test results.

1 Mar 2022

Exploring Oxford nanopore technology-based on-site SARS-CoV-2 genome sequencing

In a new study, researchers performed genomic sequencing of SARS-CoV-2-infected samples and aimed to identify the dominant variant, assess the mutation profile, and determine the sample-to-sequence turnover time.

1 Mar 2022

Impact of COVID-19 boosters on protection against SARS-CoV-2 infection in a highly vaccinated population

A recent study analyzed the impact of COVID-19 booster vaccines against the SARS-CoV-2 Omicron VOC in a vaccinated population.

1 Mar 2022

Association between booster breakthrough infections with the SARS-CoV-2 Omicron variant and time-since-vaccination

A recent study assessed the waning efficacy of the BioNTech/Pfizer BNT162b2 mRNA vaccine against the SARS-CoV-2 Omicron VOC.

1 Mar 2022

Effectiveness of Pfizer-BioNTech, Moderna, and Oxford-AstraZeneca COVID-19 vaccines in preventing severe SARS-CoV-2 infection

A new study compared the effectiveness of the Pfizer-BioNTech, Moderna, and Oxford-AstraZeneca COVID-19 vaccines in preventing SARS-CoV-2 infections.

1 Mar 2022

Vaccine News and Research

Latest Vaccine News and Research

Dual therapeutic potential of zapnometinib against COVID-19

Durability of immunity to SARS-CoV-2 reinfection among initially unvaccinated individuals with previous SARS-CoV-2 infection

Antigenic differences between Omicron BA.1 and BA.2 SARS-CoV-2 variants

Short-term change of depressive and anxiety symptoms in relation to COVID-19 vaccination

UK's bilateral donation of 1 million vaccine doses will reinforce Bangladesh’s fight against COVID-19

Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis

Government invests £260 million to support health research and life sciences manufacturing

Study reports substantial loss of protection one month after complete SARS-CoV-2 BNT162b2 immunization in children

Population-level health and economic impact of the Pfizer-BioNTech COVID-19 vaccine in first year of rollout in the US

Study finds booster shot did produce effective levels of neutralizing antibodies against omicron

Researchers launch a multi-center trial to investigate new treatment for pediatric type 1 diabetes

mRNA vaccines found to generate neutralizing antibodies against SARS-CoV-2 Omicron variant

Risk of death involving COVID-19 following infection from Omicron relative to Delta

Exploring Oxford nanopore technology-based on-site SARS-CoV-2 genome sequencing

Impact of COVID-19 boosters on protection against SARS-CoV-2 infection in a highly vaccinated population

Association between booster breakthrough infections with the SARS-CoV-2 Omicron variant and time-since-vaccination

Effectiveness of Pfizer-BioNTech, Moderna, and Oxford-AstraZeneca COVID-19 vaccines in preventing severe SARS-CoV-2 infection

Effect of mRNA-based COVID-19 vaccination in multiple myeloma patients

J&J-vaxxed, mRNA-boosted, and pondering a third shot

Estimating life expectancy changes since 2020

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in